Logo for Stayble Therapeutics

Stayble Therapeutics Investor Relations Material

Latest events

Logo for Stayble Therapeutics

CEO Sitdown with Kalqyl Q2 2023

Stayble Therapeutics
Logo for Stayble Therapeutics

Q3 2023

14 Nov, 2023
Logo for Stayble Therapeutics

CEO Sitdown with Kalqyl Q2 2023

1 Sep, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Its portfolio includes StaYble, a combination of two drugs that are already approved for use in humans and administered as separate mechanisms at complementary sites of action, with the goal of achieving synergy, which is the treatment of pain through several independent but related mechanisms.